NextCure, Inc.
corporate_fare Company Profile
NextCure, Inc. (NASDAQ:NXTC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for NXTC at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- NextCure Secures Fast Track for Lead Program, Details Q1 Financials and Cash Runway into H1 2027
- NextCure Seeks Shareholder Approval to Increase Shares for Omnibus Incentive Plan Amidst Going Concern Warning
- FDA Fast Tracks NextCure's SIM0505 for Platinum-Resistant Ovarian Cancer
- Annual Report Discloses Substantial Doubt on Going Concern, Details Recent Dilutive Capital Raises
- NextCure Secures Funding into H1 2027, Reports 2025 Results, and Advances Clinical Programs
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$55.84M
Diluted EPS
-$19.65
Op. Cash Flow
-$49.61M
Operating Income
-$57.62M
Cash & Equivalents
$25.98M
Debt / Equity
0.00×
Shares Outstanding
3.51M sh
Source: 10-K · filed 2026-03-05 · accession 0001104659-26-024137
show_chartPrice Chart
Loading chart...
feed NXTC - Filings & News (Page 2)
NXTC
May 07, 2026, 4:19 PM EDT
Price at Filing:
$10.18
Real-time Price:
$6.17
Change:
-$4.01 (-39%)
Market Cap:
$29.535M
NXTC
Apr 24, 2026, 4:18 PM EDT
Price at Filing:
$10.52
Real-time Price:
$6.17
Change:
-$4.35 (-41%)
Market Cap:
$29.535M
NXTC
Apr 07, 2026, 8:05 AM EDT
Price at Filing:
$11.37
Real-time Price:
$6.17
Change:
-$5.20 (-46%)
Market Cap:
$29.535M
NXTC
Mar 05, 2026, 4:26 PM EST
Price at Filing:
$12.76
Real-time Price:
$6.17
Change:
-$6.59 (-52%)
Market Cap:
$29.535M
NXTC
Mar 05, 2026, 4:15 PM EST
Price at Filing:
$12.76
Real-time Price:
$6.17
Change:
-$6.59 (-52%)
Market Cap:
$29.535M
NXTC
Mar 05, 2026, 4:11 PM EST
Price at Filing:
$12.76
Real-time Price:
$6.17
Change:
-$6.59 (-52%)
Market Cap:
$29.535M
NXTC
Jan 23, 2026, 7:20 AM EST
Price at Filing:
$12.65
Real-time Price:
$6.17
Change:
-$6.48 (-51%)
Market Cap:
$29.535M